These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17374431)
1. Evaluation of endothelial function in women with polycystic ovary syndrome. Lowenstein L; Damti A; Pillar G; Shott S; Blumenfeld Z Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):208-12. PubMed ID: 17374431 [TBL] [Abstract][Full Text] [Related]
2. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699 [TBL] [Abstract][Full Text] [Related]
3. Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective. Romualdi D; Costantini B; Selvaggi L; Giuliani M; Cristello F; Macrì F; Bompiani A; Lanzone A; Guido M Hum Reprod; 2008 Sep; 23(9):2127-33. PubMed ID: 18567896 [TBL] [Abstract][Full Text] [Related]
4. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Glueck CJ; Goldenberg N; Pranikoff J; Loftspring M; Sieve L; Wang P Hum Reprod; 2004 Jun; 19(6):1323-30. PubMed ID: 15117896 [TBL] [Abstract][Full Text] [Related]
5. Metformin reduces abortion in pregnant women with polycystic ovary syndrome. Khattab S; Mohsen IA; Foutouh IA; Ramadan A; Moaz M; Al-Inany H Gynecol Endocrinol; 2006 Dec; 22(12):680-4. PubMed ID: 17162710 [TBL] [Abstract][Full Text] [Related]
6. Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome. Palomba S; Russo T; Orio F; Falbo A; Manguso F; Cascella T; Tolino A; Carmina E; Colao A; Zullo F Hum Reprod; 2006 Feb; 21(2):457-65. PubMed ID: 16253975 [TBL] [Abstract][Full Text] [Related]
7. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168 [TBL] [Abstract][Full Text] [Related]
8. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism. Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643 [TBL] [Abstract][Full Text] [Related]
9. Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia. Glueck CJ; Golnik KC; Aregawi D; Goldenberg N; Sieve L; Wang P Transl Res; 2006 Nov; 148(5):215-22. PubMed ID: 17145568 [TBL] [Abstract][Full Text] [Related]
10. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome. Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426 [TBL] [Abstract][Full Text] [Related]
11. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528 [TBL] [Abstract][Full Text] [Related]
12. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Glueck CJ; Bornovali S; Pranikoff J; Goldenberg N; Dharashivkar S; Wang P Diabet Med; 2004 Aug; 21(8):829-36. PubMed ID: 15270785 [TBL] [Abstract][Full Text] [Related]
13. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance. Topcu S; Tok D; Caliskan M; Ozcimen EE; Gullu H; Uckuyu A; Erdogan D; Zeyneloglu H; Muderrisoglu H Clin Endocrinol (Oxf); 2006 Jul; 65(1):75-80. PubMed ID: 16817823 [TBL] [Abstract][Full Text] [Related]
14. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. Agarwal N; Rice SP; Bolusani H; Luzio SD; Dunseath G; Ludgate M; Rees DA J Clin Endocrinol Metab; 2010 Feb; 95(2):722-30. PubMed ID: 19996308 [TBL] [Abstract][Full Text] [Related]
15. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome. Wu J; Zhu Y; Jiang Y; Cao Y Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522 [TBL] [Abstract][Full Text] [Related]
16. The use of metformin in the management of polycystic ovary syndrome and associated anovulatory infertility: the current evidence. Leeman L; Acharya U J Obstet Gynaecol; 2009 Aug; 29(6):467-72. PubMed ID: 19697191 [TBL] [Abstract][Full Text] [Related]
17. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. Orio F; Palomba S; Cascella T; De Simone B; Manguso F; Savastano S; Russo T; Tolino A; Zullo F; Lombardi G; Azziz R; Colao A J Clin Endocrinol Metab; 2005 Nov; 90(11):6072-6. PubMed ID: 16118336 [TBL] [Abstract][Full Text] [Related]
18. C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome. Kjøtrød SB; Romundstad P; von Düring V; Sunde A; Carlsen SM Fertil Steril; 2008 Mar; 89(3):635-41. PubMed ID: 17548076 [TBL] [Abstract][Full Text] [Related]
19. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? Nawaz FH; Khalid R; Naru T; Rizvi J J Obstet Gynaecol Res; 2008 Oct; 34(5):832-7. PubMed ID: 18834342 [TBL] [Abstract][Full Text] [Related]
20. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin. Svendsen PF; Nilas L; Madsbad S; Holst JJ Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]